Hovione shortlisted for the CPhI Pharma Awards 2023!
4th European Conference on Pharmaceutics
Abstract: “Recent advances in ASD formulations: Dispersome® as alternative carrier in a high-throughput screening setup”
|Presenter: Ana Costa, Modelling & PAT Scientist at Hovione|
|Date: Monday, March 20th, 2023|
|Session: Bioavailability, absorption enhancement and in-vitro/In-vivo correlations|
|Panel number: 56|
By increasing drug solubility, the Dispersome® platform aims at improving oral bioavailability and therapeutic outcomes for patients. Dispersome® formulations are compatible with standard pharmaceutical processes and Spray Drying provides a scalable manufacturing solution.
Find more about the 4th European Conference on Pharmaceutics.